BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/CYP2D2/Compounds

Compounds That Target CYP2D2

cytochrome P450, family 2, subfamily d, polypeptide 2 · 3 compounds in BiohacksAI corpus

CYP2D2 (cytochrome P450, family 2, subfamily d, polypeptide 2) is a cytochrome P450 enzyme involved in the metabolism of drugs, hormones, and dietary compounds. CYP enzymes are critical determinants of pharmacokinetics and drug-herb interactions. The 3 compounds listed here have documented interactions with CYP2D2 based on BindingDB inhibition and binding assay data, making this resource valuable for assessing compound safety and interaction profiles.

View CYP2D2 target page →UniProt: P10634 ↗
Most Studied Compounds for CYP2D2
1
Quinidine
298+
studies
2
Dextromethorphan
296+
studies
3
Nortriptyline
295+
studies
All 3 Compounds — Ranked by Evidence
1
Dextromethorphan
296+
studies
0.69
confidence
2
Nortriptyline
295+
studies
0.69
confidence
3
Quinidine
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CYP2D2 (cytochrome P450, family 2, subfamily d, polypeptide 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CYP2D2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.